Published in Learn Mem on April 25, 2008
Neural and cellular mechanisms of fear and extinction memory formation. Neurosci Biobehav Rev (2012) 1.94
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol (2012) 1.40
The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev (2015) 1.38
CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency. Pflugers Arch (2009) 1.26
L-type Ca(2+) channels in heart and brain. Wiley Interdiscip Rev Membr Transp Signal (2014) 1.06
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther (2014) 0.92
Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions. PLoS One (2011) 0.91
Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol (2015) 0.89
Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders. Br J Pharmacol (2014) 0.86
Genetic disruptions of Drosophila Pavlovian learning leave extinction learning intact. Genes Brain Behav (2009) 0.85
Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets? Curr Mol Pharmacol (2015) 0.81
From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms. Neurotherapeutics (2017) 0.80
Satb2 determines miRNA expression and long-term memory in the adult central nervous system. Elife (2016) 0.78
L-type calcium channels as drug targets in CNS disorders. Channels (Austin) (2015) 0.75
Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol Psychiatry (2002) 6.67
MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci (2004) 5.95
Mechanisms of fear extinction. Mol Psychiatry (2006) 5.44
International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev (2005) 5.25
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08
Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci (2004) 4.99
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
Conditioned and unconditional components of post-shock freezing. Pavlov J Biol Sci (1981) 4.20
The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev (1999) 3.66
Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J Cell Biol (1993) 3.54
Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci (1992) 3.40
Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci (2004) 2.88
Signaling from synapse to nucleus: the logic behind the mechanisms. Curr Opin Neurobiol (2003) 2.42
Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem (2001) 2.31
Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci (2005) 2.27
Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction. Learn Mem (2004) 2.23
NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci (2002) 2.20
Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry (2006) 2.11
Regulation of synaptic plasticity genes during consolidation of fear conditioning. J Neurosci (2002) 2.10
Regional expression and cellular localization of the alpha1 and beta subunit of high voltage-activated calcium channels in rat brain. J Neurosci (1997) 2.05
Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. J Neurosci (2001) 2.05
The L-Type voltage-gated calcium channel Cav1.3 mediates consolidation, but not extinction, of contextually conditioned fear in mice. Learn Mem (2006) 1.87
Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats. J Neurosci (1998) 1.82
Extinction of auditory fear conditioning requires MAPK/ERK activation in the basolateral amygdala. Eur J Neurosci (2006) 1.73
Resistance to extinction is associated with impaired immediate early gene induction in medial prefrontal cortex and amygdala. Eur J Neurosci (2004) 1.70
Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels. J Clin Invest (2004) 1.69
L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J Neurosci (2002) 1.61
Building and burying fear memories in the brain. Neuroscientist (2005) 1.57
Excitation-transcription coupling: signaling by ion channels to the nucleus. Sci STKE (2003) 1.55
The place of the hippocampus in fear conditioning. Eur J Pharmacol (2003) 1.55
D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry (2005) 1.53
Neuronal L-type calcium channels open quickly and are inhibited slowly. J Neurosci (2005) 1.43
L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala. J Neurosci (1999) 1.42
Localization of mRNAs of voltage-dependent Ca(2+)-channels: four subtypes of alpha 1- and beta-subunits in developing and mature rat brain. Brain Res Mol Brain Res (1995) 1.40
The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav Neurosci (1996) 1.33
Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications. Learn Mem (2004) 1.31
LTP is accompanied by commensurate enhancement of auditory-evoked responses in a fear conditioning circuit. Neuron (1995) 1.30
The L-type calcium channel blocker nifedipine impairs extinction, but not reduced contingency effects, in mice. Learn Mem (2005) 1.29
Association of CaV1.3 L-type calcium channels with Shank. J Neurosci (2005) 1.25
Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev (2007) 1.22
Recalling safety: cooperative functions of the ventromedial prefrontal cortex and the hippocampus in extinction. CNS Spectr (2007) 1.20
Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med (2006) 1.18
L-type voltage-gated calcium channels are involved in the in vivo and in vitro expression of fear conditioning. Ann N Y Acad Sci (2003) 1.15
Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels. Neuroscience (2003) 1.13
Subunit-dependent modulation of recombinant L-type calcium channels. Molecular basis for dihydropyridine tissue selectivity. Circ Res (1993) 1.00
Brain activation pattern induced by stimulation of L-type Ca2+-channels: contribution of Ca(V)1.3 and Ca(V)1.2 isoforms. Neuroscience (2006) 0.98
Calcium channel activation and self-biting in mice. Proc Natl Acad Sci U S A (1999) 0.96
Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. Eur J Biochem (1985) 0.90
Neuronal localization of Ca(v)1.2 L-type calcium channels in the rat basolateral amygdala. Brain Res (2005) 0.90
L-type calcium channel ligands block nicotine-induced signaling to CREB by inhibiting nicotinic receptors. Neuropharmacology (2006) 0.89
Potentiated amygdaloid auditory-evoked potentials and freezing behavior after fear conditioning in mice. Brain Res (2001) 0.86
Aging-related increase in hippocampal calcium channels. Life Sci (1996) 0.85
Interactions between clonidine and antidepressant drugs: a method for identifying antidepressant-like agents. Neuropharmacology (1978) 0.82
Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures. Epilepsia (1992) 0.82
Opposite central cardiovascular effects of nifedipine and BAY k 8644 in anesthetized rats. Hypertension (1987) 0.80
Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses. Brain Res (2003) 0.79
Antihypertensive effects of nifedipine on conscious normotensive and hypertensive rats. J Pharmacobiodyn (1981) 0.79
Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells. Brain Res (1994) 0.78
Neuropsychological profiles of calcium antagonists. Fundam Clin Pharmacol (1989) 0.77
Cardiovascular and renal actions of calcium channel blocker chemical subgroups: a search for renal specificity. J Pharm Pharmacol (1988) 0.77
Antianxiety actions of Ca2+ channel antagonists with Vogel-type conflict test in rats. Eur J Pharmacol (1994) 0.76
Cellular mechanisms underlying cognition-enhancing actions of nefiracetam (DM-9384). Behav Brain Res (1997) 0.76
Central cardiovascular effects of dihydropyridines in spontaneously hypertensive rats. Fundam Clin Pharmacol (1989) 0.76
Potential serotonergic interactions with the anxiolytic-like effects of calcium channel antagonists. Pharmacol Biochem Behav (1998) 0.76
Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J Neurosci (2008) 2.87
Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A (2003) 2.60
Neuronal circuits of fear extinction. Eur J Neurosci (2010) 2.49
Neurobiology of migraine. Nat Rev Neurosci (2003) 2.39
Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proc Natl Acad Sci U S A (2008) 2.04
Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci (2010) 2.00
Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain. Proc Natl Acad Sci U S A (2010) 1.85
Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels. J Clin Invest (2004) 1.69
C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. Nat Neurosci (2006) 1.69
A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proc Natl Acad Sci U S A (2005) 1.65
Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology (2008) 1.53
Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation. J Neurosci (2003) 1.47
Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol (2008) 1.40
Different fear states engage distinct networks within the intercalated cell clusters of the amygdala. J Neurosci (2011) 1.39
Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. J Biol Chem (2011) 1.37
Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. J Neurosci (2010) 1.37
Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci (2003) 1.36
Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. J Biol Chem (2008) 1.32
Induction of deltaFosB in the periaqueductal gray by stress promotes active coping responses. Neuron (2007) 1.31
Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci U S A (2004) 1.30
Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci Biobehav Rev (2006) 1.30
The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci (2010) 1.29
Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle. Am J Physiol Heart Circ Physiol (2007) 1.28
Voltage-dependent calcium channels and cardiac pacemaker activity: from ionic currents to genes. Prog Biophys Mol Biol (2005) 1.27
Impaired extinction of learned fear in rats selectively bred for high anxiety--evidence of altered neuronal processing in prefrontal-amygdala pathways. Eur J Neurosci (2008) 1.26
Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction. J Neurosci (2010) 1.25
A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels. J Neurosci (2008) 1.22
Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids. Neuropsychopharmacology (2005) 1.21
Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Ca(v)1.4 L-type Ca2+ channels. J Neurosci (2005) 1.18
Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J Biol Chem (2001) 1.16
Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. J Neurosci (2004) 1.11
Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes. Neuropsychopharmacology (2012) 1.11
CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. Int J Neuropsychopharmacol (2009) 1.10
Voltage-dependent calcium channel CaV1.3 subunits regulate the light peak of the electroretinogram. J Neurophysiol (2007) 1.10
Individual differences in recovery from traumatic fear. Trends Neurosci (2012) 1.10
Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance. Nitric Oxide (2004) 1.09
The role of physiological afferent nerve activity during in vivo maturation of the calyx of Held synapse. J Neurosci (2007) 1.07
Functional roles of Ca(v)1.3, Ca(v)3.1 and HCN channels in automaticity of mouse atrioventricular cells: insights into the atrioventricular pacemaker mechanism. Channels (Austin) (2011) 1.07
Role of Cav1.2 L-type Ca2+ channels in vascular tone: effects of nifedipine and Mg2+. Am J Physiol Heart Circ Physiol (2006) 1.07
The modulatory role of the lateral septum on neuroendocrine and behavioral stress responses. Neuropsychopharmacology (2010) 1.07
Genetic predisposition to anxiety-related behavior determines coping style, neuroendocrine responses, and neuronal activation during social defeat. Behav Neurosci (2006) 1.06
Single dose of L-dopa makes extinction memories context-independent and prevents the return of fear. Proc Natl Acad Sci U S A (2013) 1.05
Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry. Ann N Y Acad Sci (2008) 1.05
Tachykinin receptors as therapeutic targets in stress-related disorders. Curr Pharm Des (2009) 1.04
Modulation of Cav1.3 Ca2+ channel gating by Rab3 interacting molecule. Mol Cell Neurosci (2010) 1.01
Functional properties and modulation of extracellular epitope-tagged Ca(V)2.1 voltage-gated calcium channels. Channels (Austin) (2008) 0.99
Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating: evidence for beta-subunit isoform-specific effects. J Biol Chem (2004) 0.99
Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology (2012) 0.98
Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety. PLoS One (2009) 0.98
Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats. Biol Psychiatry (2004) 0.97
Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.96
Activity and calcium regulate nuclear targeting of the calcium channel beta4b subunit in nerve and muscle cells. Channels (Austin) (2009) 0.96
A hypomorphic vasopressin allele prevents anxiety-related behavior. PLoS One (2009) 0.96
Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission. Neuropsychopharmacology (2007) 0.95
Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior. Neuropsychopharmacology (2013) 0.95
Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J Neurochem (2005) 0.94
Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. J Neurosci (2007) 0.93
Cav1.3 calcium channels are required for normal development of the auditory brainstem. J Neurosci (2011) 0.93
Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity. J Neurosci (2010) 0.93
The monoclonal antibody mAB 1A binds to the excitation--contraction coupling domain in the II-III loop of the skeletal muscle calcium channel alpha(1S) subunit. Arch Biochem Biophys (2004) 0.92
Magnesium-deficient diet alters depression- and anxiety-related behavior in mice--influence of desipramine and Hypericum perforatum extract. Neuropharmacology (2004) 0.92
Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biol Psychiatry (2007) 0.92
Effects of congenital stationary night blindness type 2 mutations R508Q and L1364H on Cav1.4 L-type Ca2+ channel function and expression. J Neurochem (2006) 0.92
Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions. PLoS One (2011) 0.91
Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence. Exp Neurol (2013) 0.91
Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment. Neuropharmacology (2002) 0.91
L-type Ca2+ channels in Ca2+ channelopathies. Biochem Biophys Res Commun (2004) 0.90
Pacemaker activity and ionic currents in mouse atrioventricular node cells. Channels (Austin) (2011) 0.90
The clinical implications of mouse models of enhanced anxiety. Future Neurol (2011) 0.89
Structural determinants of CaV1.3 L-type calcium channel gating. Channels (Austin) (2012) 0.89
Decreased social interaction in aged rats may not reflect changes in anxiety-related behaviour. Behav Brain Res (2004) 0.89
Diabetes insipidus and, partially, low anxiety-related behaviour are linked to a SNP-associated vasopressin deficit in LAB mice. Eur J Neurosci (2007) 0.89
Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.89
Increased in vivo release of neuropeptide S in the amygdala of freely moving rats after local depolarisation and emotional stress. Amino Acids (2011) 0.87
Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacology (2006) 0.87
Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino Acids (2011) 0.87
High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats. Neuroimage (2004) 0.87
Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics (2007) 0.87
Circadian abnormalities in a mouse model of high trait anxiety and depression. Ann Med (2014) 0.87
Are Ca(v)1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage. Channels (Austin) (2011) 0.85
Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile. J Med Chem (2009) 0.85
Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Psychopharmacology (Berl) (2006) 0.84
Calcium channels in mouse hair cells: function, properties and pharmacology. Adv Otorhinolaryngol (2002) 0.84
Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice. Neuropharmacology (2012) 0.84
5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats. Psychopharmacology (Berl) (2006) 0.84
Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion. Eur J Neurosci (2002) 0.82